Pfizer – which first agreed a $4.9 billion takeover deal with Metsera in September – has argued that the rival bid is ...
Although rare kidney diseases remain a significantly overlooked contributor to the global burden of CKD, things have begun to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback